Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Optimizing biological therapy in Crohn's disease
Krisztina Barbara Gecse
, Zsuzsanna Végh
, Péter László Lakatos
*
*
Corresponding author for this work
Gastroenterology and Hepatology
Amsterdam Gastroenterology Endocrinology Metabolism
Affiliatie UvA
Semmelweis University
Research output
:
Contribution to journal
›
Review article
›
Academic
›
peer-review
102
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Optimizing biological therapy in Crohn's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Crohn's Disease
100%
Biological Treatment
33%
Ulcerative Colitis
33%
Inflammatory Bowel Disease
33%
Outcome Prediction
33%
Therapeutic Drug Monitoring
33%
Anti-TNF Therapy
33%
Loss of Response
33%
Anti-TNF Agents
33%
Anti-TNF Biologicals
33%
Efficacy Prediction
33%
Nursing and Health Professions
Crohn's Disease
100%
Tumor Necrosis Factor
66%
Ulcerative Colitis
33%
Inflammatory Bowel Disease
33%
Therapeutic Drug Monitoring
33%
Tumor Necrosis Factor Inhibitor
33%
Efficacy
33%
Medicine and Dentistry
Crohn's Disease
100%
Tumor Necrosis Factor
66%
Inflammatory Bowel Disease
33%
Ulcerative Colitis
33%
TNF Inhibitor
33%
Therapeutic Drug Monitoring
33%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Tumor Necrosis Factor
66%
Ulcerative Colitis
33%
Inflammatory Bowel Disease
33%
Therapeutic Drug Monitoring
33%
Tumor Necrosis Factor Inhibitor
33%